WHO guidelines for treatment of severe pneumonia

Lancet

Volumn 370, Issue 9585, 2007, Pages 386-387

  Madhi, Shabir A ^a   Albrich, Werner ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ALGORITHM; ANTIBIOTIC THERAPY; HUMAN; LETTER; MYCOBACTERIUM TUBERCULOSIS; PNEUMOCYSTIS JIROVECI; PNEUMONIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATORY VIRUS; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE; VIRAL RESPIRATORY TRACT INFECTION; WORLD HEALTH ORGANIZATION;

EID: 34547576464     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)61188-X     Document Type: Letter

References (5)

1. McNally L., Jeena P., Gajee K., et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet 369 (2007) 1440-1451
2. Madhi S., and Klugman K. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 10 (2004) 811-813
3. Graham S., Mtitimila E., Kamanga H., Walsh A., Hart C., and Molyneux M. Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian children. Lancet 355 (2000) 369-373
4. Madhi S., Petersen K., Madhi A., Khoosal M., and Klugman K. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis 31 (2000) 170-176
5. Zar H., Hanslo D., Tannenbaum E., et al. Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospitalized in South Africa. Acta Paediatr 90 (2001) 119-125